4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-025856
Director sold 40,000 shares at an average $36.55 ($1,462,089)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Socks David A Director | 2021-04-05 | Sale | −12,619 | $35.69 | $450,337 | 1,368,326 | I |
| Socks David A Director | 2021-04-05 | Sale | −7,769 | $36.40 | $282,793 | 1,360,557 | I |
| Socks David A Director | 2021-04-05 | Sale | −1,730 | $37.15 | $64,275 | 1,358,827 | I |
| Socks David A Director | 2021-04-06 | Sale | −1,400 | $34.96 | $48,945 | 1,357,427 | I |
| Socks David A Director | 2021-04-06 | Sale | −3,359 | $35.97 | $120,823 | 1,354,068 | I |
| Socks David A Director | 2021-04-06 | Sale | −6,328 | $37.37 | $236,501 | 1,347,740 | I |
| Socks David A Director | 2021-04-06 | Sale | −6,795 | $38.03 | $258,415 | 1,340,945 | I |
| Open-market sales · 40,000 sh · avg $36.55 · $1,462,089 | |||||||
Loading xslF345X03/doc4.xml…